ST. PAUL, Minn., April 6, 2015 /PRNewswire/ -- Ground-breaking new cystic fibrosis treatments, that target the gene mutations causing the disease, will significantly increase health care costs. This is the finding of new research by pharmacy benefit manager Prime Therapeutics LLC...